Growth Metrics

Astria Therapeutics (ATXS) Interest & Investment Income: 2016-2018

Historic Interest & Investment Income for Astria Therapeutics (ATXS) over the last 3 years, with Dec 2018 value amounting to $425,000.

  • Astria Therapeutics' Interest & Investment Income rose 440.62% to $173,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $425,000, marking a year-over-year increase of 165.62%. This contributed to the annual value of $425,000 for FY2018, which is 165.62% up from last year.
  • According to the latest figures from FY2018, Astria Therapeutics' Interest & Investment Income is $425,000, which was up 165.62% from $160,000 recorded in FY2017.
  • In the past 5 years, Astria Therapeutics' Interest & Investment Income ranged from a high of $425,000 in FY2018 and a low of $160,000 during FY2017.
  • For the 3-year period, Astria Therapeutics' Interest & Investment Income averaged around $275,667, with its median value being $242,000 (2016).
  • Per our database at Business Quant, Astria Therapeutics' Interest & Investment Income crashed by 33.88% in 2017 and then spiked by 165.62% in 2018.
  • Astria Therapeutics' Interest & Investment Income (Yearly) stood at $242,000 in 2016, then slumped by 33.88% to $160,000 in 2017, then skyrocketed by 165.62% to $425,000 in 2018.